Pluri Inc
NASDAQ:PLUR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pluri Inc
NASDAQ:PLUR
|
IL |
|
Atlanta Braves Holdings Inc
F:E450
|
US |
|
H
|
Honghua Group Ltd
F:4HB
|
CN |
|
N
|
Neorigin Co Ltd
KOSDAQ:094860
|
KR |
|
PCI- PAL PLC
LSE:PCIP
|
UK |
|
A
|
Ansell Ltd
OTC:ANSLF
|
AU |
|
C
|
Cresud SACIF y A
F:CD8
|
AR |
|
T
|
Thumbage Co Ltd
KOSDAQ:208640
|
KR |
|
R
|
Ratch Group PCL
SET:RATCH
|
TH |
Intrinsic Value
Is PLUR undervalued or overvalued?
See the intrinsic value estimate for Pluri Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PLUR looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PLUR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Pluri Does
Pluri Inc is a biotechnology company built around living cell products. It develops placenta-derived cell therapies and the systems used to grow and process those cells in the lab. Its main work is aimed at medical uses such as helping treat inflammatory, ischemic, and blood-related diseases, where standard drugs may not be enough.
- Headquarters
- Israel IL
- Employees
- 129
- IPO date
- Dec 10, 2007
Earnings Waterfall
Pluri Inc
The intrinsic value for Pluri Inc (PLUR) under the Base Case is hidden USD.
Compared with the current market price of 1.01 USD, the stock appears hidden.